Healthcare provider profile · identity verified

Stuti Shankar, M.D.

Internal Medicine · BROOKFIELD, WI · NPI 1710099379

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	616	182
Levothyroxine Sodium	Levothyroxine Sodium	476	118
Amlodipine Besylate	Amlodipine Besylate	356	107
Lisinopril	Lisinopril	347	99
Losartan Potassium	Losartan Potassium	327	93
Rosuvastatin Calcium	Rosuvastatin Calcium	293	89
Metformin Hcl Er	Metformin Hcl	223	72
Metoprolol Succinate	Metoprolol Succinate	211	54
Omeprazole	Omeprazole	208	57
Gabapentin	Gabapentin	207	52
Furosemide	Furosemide	196	62
Simvastatin	Simvastatin	169	49
Pantoprazole Sodium	Pantoprazole Sodium	162	49
Metformin Hcl	Metformin Hcl	123	30
Sertraline Hcl	Sertraline Hcl	121	36
Escitalopram Oxalate	Escitalopram Oxalate	117	33
Famotidine	Famotidine	105	24
Hydrochlorothiazide	Hydrochlorothiazide	105	35
Alendronate Sodium	Alendronate Sodium	103	28
Pravastatin Sodium	Pravastatin Sodium	99	33
Eliquis	Apixaban	97	31
Warfarin Sodium	Warfarin Sodium	94	18
Duloxetine Hcl	Duloxetine Hcl	91	29
Mounjaro	Tirzepatide	88	15
Trazodone Hcl	Trazodone Hcl	83	30
Allopurinol	Allopurinol	78	24
Carvedilol	Carvedilol	78	25
Fluticasone Propionate	Fluticasone Propionate	77	27
Ozempic	Semaglutide	76	17
Chlorthalidone	Chlorthalidone	74	23
Albuterol Sulfate Hfa	Albuterol Sulfate	73	34
Jardiance	Empagliflozin	70	22
Venlafaxine Hcl Er	Venlafaxine Hcl	66	17
Metoprolol Tartrate	Metoprolol Tartrate	62	18
Tamsulosin Hcl	Tamsulosin Hcl	61	19
Tramadol Hcl	Tramadol Hcl	61	14
Montelukast Sodium	Montelukast Sodium	59	16
Clopidogrel	Clopidogrel Bisulfate	57	14
Spironolactone	Spironolactone	57	15
Lovastatin	Lovastatin	56	11
Citalopram Hbr	Citalopram Hydrobromide	55	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	23
Potassium Chloride	Potassium Chloride	54	19
Bupropion Xl	Bupropion Hcl	53	18
Atenolol	Atenolol	48	13
Synthroid	Levothyroxine Sodium	47	suppressed
Xarelto	Rivaroxaban	44	suppressed
Paroxetine Hcl	Paroxetine Hcl	42	suppressed
Buspirone Hcl	Buspirone Hcl	40	suppressed
Valacyclovir	Valacyclovir Hcl	40	18
Estradiol	Estradiol	39	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	38	24
Propranolol Hcl Er	Propranolol Hcl	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	11
Trulicity	Dulaglutide	36	suppressed
Lorazepam	Lorazepam	33	13
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Meloxicam	Meloxicam	30	suppressed
Prazosin Hcl	Prazosin Hcl	30	suppressed
Donepezil Hcl	Donepezil Hcl	29	suppressed
Ketoconazole	Ketoconazole	29	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	29	13
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	13
Benazepril Hcl	Benazepril Hcl	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Pregabalin	Pregabalin	24	11
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Prednisone	Prednisone	23	13
Triamcinolone Acetonide	Triamcinolone Acetonide	23	suppressed
Finasteride	Finasteride	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	12
Ibuprofen	Ibuprofen	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	11
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	21	suppressed
Glipizide	Glipizide	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	20	suppressed
Ondansetron Odt	Ondansetron	19	12
Baclofen	Baclofen	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	16
Lidocaine	Lidocaine	17	suppressed
Valsartan	Valsartan	17	suppressed
Myrbetriq	Mirabegron	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Topiramate	Topiramate	16	suppressed
Rybelsus	Semaglutide	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Victoza 3-Pak	Liraglutide	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Fluvastatin Sodium	Fluvastatin Sodium	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Cilostazol	Cilostazol	11	suppressed
Diazepam	Diazepam	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Lescol Xl	Fluvastatin Sodium	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Ramipril	Ramipril	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error